Cargando…
Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma
Objective: Head and neck squamous cell carcinoma (HNSCC) is a common heterogeneous cancer with complex carcinogenic factors. However, the current TNM staging criteria to judge its severity to formulate treatment plans and evaluate the prognosis are particularly weak. Therefore, a robust diagnostic m...
Autores principales: | Liu, Shixian, Liu, Weiwei, Ding, Zhao, Yang, Xue, Jiang, Yuan, Wu, Yu, Liu, Yehai, Wu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631213/ https://www.ncbi.nlm.nih.gov/pubmed/36339718 http://dx.doi.org/10.3389/fmolb.2022.912620 |
Ejemplares similares
-
Effective TME-related signature to predict prognosis of patients with head and neck squamous cell carcinoma
por: Wan, Lingfei, et al.
Publicado: (2023) -
Validation of Gene Profiles for Analysis of Regional Lymphatic Metastases in Head and Neck Squamous Cell Carcinoma
por: Hu, Zhenrong, et al.
Publicado: (2020) -
Identification of HOXA1 as a Novel Biomarker in Prognosis of Head and Neck Squamous Cell Carcinoma
por: Li, Hui, et al.
Publicado: (2021) -
Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma
por: Yin, Ji, et al.
Publicado: (2021) -
A Neutrophil Extracellular Traps Signature Predicts the Clinical Outcomes and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Chen, Naifei, et al.
Publicado: (2022)